Biothrax Market 2027 By Vaccine Type, Application, End-User | The Insight Partners

Biothrax Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Vaccine Type (Cell-Free PA Vaccines, Live Vaccines); Application (Human Use, Animal Use); End-User (Hospital, Clinics, Vaccination Centers, Others)

Report Code: TIPRE00014259 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

BioThrax is a vaccine indicated for the active immunization for the prevention of disease caused by Bacillus anthracis in persons 18 through 65 years of age.

MARKET DYNAMICS

The biothrax market is driving due to the increased eating of undercooked or raw meat from infected animals. However, less awareness amongst the people in the underdeveloped region may hinder the market growth in the review period.

MARKET SCOPE

The "Biothrax Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of biothrax market with detailed market segmentation by vaccine type, application, and end-user. The biothrax market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biothrax market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The biothrax market is segmented on the basis of vaccine type, application, and end-user. On the basis of vaccine type, the market is categorized as cell-free PA vaccines and live vaccines. On the basis of application, the market is segmented into human use and animal use. On the basis of end-user, the market is segmented into hospital, clinics, vaccination centers and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biothrax market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biothrax market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting biothrax market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the biothrax market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the biothrax market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biothrax market are anticipated to have lucrative growth opportunities in the future with the rising demand for biothrax in the global market. Below mentioned is the list of few companies engaged in the biothrax market.

The report also includes the profiles of key players in biothrax market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Merck & Co., Inc.
  •  Emergent Bio-Solutions
  •  Zoetis, Inc.
  •  PharmAthene, Inc.
  •  Biogenesis Bago S.A.
  •  Porton Biopharma Limited
  •  Colorado Serum
  •  Merial (a Sanofi Company)
  •  VIDO-InterVac
  •  Vecol

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biothrax Market - By Vaccine Type
1.3.2 Biothrax Market - By Application
1.3.3 Biothrax Market - By End-User
1.3.4 Biothrax Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOTHRAX MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOTHRAX MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOTHRAX MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOTHRAX - GLOBAL MARKET OVERVIEW
6.2. BIOTHRAX - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOTHRAX MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TYPE
7.1. OVERVIEW
7.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
7.3. CELL-FREE PA VACCINES
7.3.1. Overview
7.3.2. Cell-Free PA Vaccines Market Forecast and Analysis
7.4. LIVE VACCINES
7.4.1. Overview
7.4.2. Live Vaccines Market Forecast and Analysis
8. BIOTHRAX MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HUMAN USE
8.3.1. Overview
8.3.2. Human Use Market Forecast and Analysis
8.4. ANIMAL USE
8.4.1. Overview
8.4.2. Animal Use Market Forecast and Analysis
9. BIOTHRAX MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. VACCINATION CENTERS
9.5.1. Overview
9.5.2. Vaccination Centers Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. BIOTHRAX MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Biothrax Market Overview
10.1.2 North America Biothrax Market Forecasts and Analysis
10.1.3 North America Biothrax Market Forecasts and Analysis - By Vaccine Type
10.1.4 North America Biothrax Market Forecasts and Analysis - By Application
10.1.5 North America Biothrax Market Forecasts and Analysis - By End-User
10.1.6 North America Biothrax Market Forecasts and Analysis - By Countries
10.1.6.1 United States Biothrax Market
10.1.6.1.1 United States Biothrax Market by Vaccine Type
10.1.6.1.2 United States Biothrax Market by Application
10.1.6.1.3 United States Biothrax Market by End-User
10.1.6.2 Canada Biothrax Market
10.1.6.2.1 Canada Biothrax Market by Vaccine Type
10.1.6.2.2 Canada Biothrax Market by Application
10.1.6.2.3 Canada Biothrax Market by End-User
10.1.6.3 Mexico Biothrax Market
10.1.6.3.1 Mexico Biothrax Market by Vaccine Type
10.1.6.3.2 Mexico Biothrax Market by Application
10.1.6.3.3 Mexico Biothrax Market by End-User
10.2. EUROPE
10.2.1 Europe Biothrax Market Overview
10.2.2 Europe Biothrax Market Forecasts and Analysis
10.2.3 Europe Biothrax Market Forecasts and Analysis - By Vaccine Type
10.2.4 Europe Biothrax Market Forecasts and Analysis - By Application
10.2.5 Europe Biothrax Market Forecasts and Analysis - By End-User
10.2.6 Europe Biothrax Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Biothrax Market
10.2.6.1.1 Germany Biothrax Market by Vaccine Type
10.2.6.1.2 Germany Biothrax Market by Application
10.2.6.1.3 Germany Biothrax Market by End-User
10.2.6.2 France Biothrax Market
10.2.6.2.1 France Biothrax Market by Vaccine Type
10.2.6.2.2 France Biothrax Market by Application
10.2.6.2.3 France Biothrax Market by End-User
10.2.6.3 Italy Biothrax Market
10.2.6.3.1 Italy Biothrax Market by Vaccine Type
10.2.6.3.2 Italy Biothrax Market by Application
10.2.6.3.3 Italy Biothrax Market by End-User
10.2.6.4 Spain Biothrax Market
10.2.6.4.1 Spain Biothrax Market by Vaccine Type
10.2.6.4.2 Spain Biothrax Market by Application
10.2.6.4.3 Spain Biothrax Market by End-User
10.2.6.5 United Kingdom Biothrax Market
10.2.6.5.1 United Kingdom Biothrax Market by Vaccine Type
10.2.6.5.2 United Kingdom Biothrax Market by Application
10.2.6.5.3 United Kingdom Biothrax Market by End-User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Biothrax Market Overview
10.3.2 Asia-Pacific Biothrax Market Forecasts and Analysis
10.3.3 Asia-Pacific Biothrax Market Forecasts and Analysis - By Vaccine Type
10.3.4 Asia-Pacific Biothrax Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Biothrax Market Forecasts and Analysis - By End-User
10.3.6 Asia-Pacific Biothrax Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Biothrax Market
10.3.6.1.1 Australia Biothrax Market by Vaccine Type
10.3.6.1.2 Australia Biothrax Market by Application
10.3.6.1.3 Australia Biothrax Market by End-User
10.3.6.2 China Biothrax Market
10.3.6.2.1 China Biothrax Market by Vaccine Type
10.3.6.2.2 China Biothrax Market by Application
10.3.6.2.3 China Biothrax Market by End-User
10.3.6.3 India Biothrax Market
10.3.6.3.1 India Biothrax Market by Vaccine Type
10.3.6.3.2 India Biothrax Market by Application
10.3.6.3.3 India Biothrax Market by End-User
10.3.6.4 Japan Biothrax Market
10.3.6.4.1 Japan Biothrax Market by Vaccine Type
10.3.6.4.2 Japan Biothrax Market by Application
10.3.6.4.3 Japan Biothrax Market by End-User
10.3.6.5 South Korea Biothrax Market
10.3.6.5.1 South Korea Biothrax Market by Vaccine Type
10.3.6.5.2 South Korea Biothrax Market by Application
10.3.6.5.3 South Korea Biothrax Market by End-User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Biothrax Market Overview
10.4.2 Middle East and Africa Biothrax Market Forecasts and Analysis
10.4.3 Middle East and Africa Biothrax Market Forecasts and Analysis - By Vaccine Type
10.4.4 Middle East and Africa Biothrax Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Biothrax Market Forecasts and Analysis - By End-User
10.4.6 Middle East and Africa Biothrax Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Biothrax Market
10.4.6.1.1 South Africa Biothrax Market by Vaccine Type
10.4.6.1.2 South Africa Biothrax Market by Application
10.4.6.1.3 South Africa Biothrax Market by End-User
10.4.6.2 Saudi Arabia Biothrax Market
10.4.6.2.1 Saudi Arabia Biothrax Market by Vaccine Type
10.4.6.2.2 Saudi Arabia Biothrax Market by Application
10.4.6.2.3 Saudi Arabia Biothrax Market by End-User
10.4.6.3 U.A.E Biothrax Market
10.4.6.3.1 U.A.E Biothrax Market by Vaccine Type
10.4.6.3.2 U.A.E Biothrax Market by Application
10.4.6.3.3 U.A.E Biothrax Market by End-User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Biothrax Market Overview
10.5.2 South and Central America Biothrax Market Forecasts and Analysis
10.5.3 South and Central America Biothrax Market Forecasts and Analysis - By Vaccine Type
10.5.4 South and Central America Biothrax Market Forecasts and Analysis - By Application
10.5.5 South and Central America Biothrax Market Forecasts and Analysis - By End-User
10.5.6 South and Central America Biothrax Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Biothrax Market
10.5.6.1.1 Brazil Biothrax Market by Vaccine Type
10.5.6.1.2 Brazil Biothrax Market by Application
10.5.6.1.3 Brazil Biothrax Market by End-User
10.5.6.2 Argentina Biothrax Market
10.5.6.2.1 Argentina Biothrax Market by Vaccine Type
10.5.6.2.2 Argentina Biothrax Market by Application
10.5.6.2.3 Argentina Biothrax Market by End-User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOTHRAX MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. BIOTHRAX MARKET, KEY COMPANY PROFILES
13.1. MERCK AND CO., INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. EMERGENT BIO-SOLUTIONS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ZOETIS, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PHARMATHENE, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOGENESIS BAGO S.A.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PORTON BIOPHARMA LIMITED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. COLORADO SERUM
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERIAL (A SANOFI COMPANY)
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. VIDO-INTERVAC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. VECOL
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Merck & Co., Inc.
2. Emergent Bio-Solutions
3. Zoetis, Inc.
4. PharmAthene, Inc.
5. Biogenesis Bago S.A.
6. Porton Biopharma Limited
7. Colorado Serum
8. Merial (a Sanofi Company)
9. VIDO-InterVac
10. Vecol

TIPRE00014259
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking